Could you provide standardized critical‑care nursing note templates for common scenarios such as sepsis/shock, acute respiratory distress syndrome, post‑operative cardiac surgery, severe traumatic brain injury, acute ischemic stroke, myocardial infarction with cardiogenic shock, diabetic ketoacidosis, and acute renal failure?

Critical Care Nursing Note Templates

Standardized nursing documentation templates improve clinical communication, ensure comprehensive assessment, and support quality care delivery in critical care settings 1, 2, 3. Below are evidence-based templates for common critical care scenarios, structured to capture essential clinical data systematically.

---

1. Sepsis/Septic Shock Template

Initial Assessment (0-15 minutes)

Vital Signs & Hemodynamics:

• Blood pressure (MAP target >65 mmHg)
• Heart rate, respiratory rate
• Temperature (check q4h minimum) 4
• Capillary refill (<2 seconds target) 4
• Mental status (alert/confused/obtunded)
• Urine output (target >0.5 mL/kg/hr) 4

Perfusion Assessment:

• Peripheral pulses (differential between central/peripheral)
• Extremity temperature (warm vs. cold shock)
• Skin mottling present: Yes/No
• Lactate level (initial and serial) 5

Fluid Resuscitation (First Hour):

• Crystalloid boluses administered: ___ mL (20 mL/kg increments) 4
• Total volume given: ___ mL
• Response to fluids: Improved/No change/Hepatomegaly or rales developed 4

Vasopressor/Inotrope Support:

• Agent: Norepinephrine/Dopamine/Epinephrine/Vasopressin
• Dose: ___ mcg/kg/min
• Route: Central/Peripheral/IO 4
• Time initiated: ___

Antibiotic Administration:

• Time sepsis identified: ___
• Blood cultures obtained: Yes/No/Time: ___
• Antibiotic given: ___ at time: ___ (target <1 hour from identification) 4

Ongoing Monitoring (Hourly)

• ScvO2 if available (target ≥70%) 4
• Cardiac index if measured (target 3.3-6.0 L/min/m²) 4
• Vasopressor requirements trending up/down/stable
• Cumulative fluid balance: ___ mL

---

2. Acute Respiratory Distress Syndrome (ARDS) Template

Respiratory Assessment

Ventilator Settings:

• Mode: ___
• Tidal volume: ___ mL (target 6 mL/kg predicted body weight) 6
• Plateau pressure: ___ cm H₂O (target ≤30 cm H₂O) 6
• PEEP: ___ cm H₂O
• FiO₂: ___
• PaO₂/FiO₂ ratio: ___ (Mild >200, Moderate 100-200, Severe <100) 6

Positioning:

• Current position: Supine/Prone
• If PaO₂/FiO₂ <150: Prone positioning initiated Yes/No 6
• Head of bed elevation: 30-45 degrees 6

Neuromuscular Blockade:

• If PaO₂/FiO₂ <150: NMB agent given Yes/No
• Agent: ___ Duration: ___ (target ≤48 hours) 6

Fluid Management:

• Strategy: Conservative/Liberal
• Net fluid balance 24h: ___ mL 6
• Signs of tissue hypoperfusion: Yes/No

Weaning Assessment:

• Patient arousable: Yes/No
• Hemodynamically stable (no vasopressors): Yes/No
• No new serious conditions: Yes/No
• Low PEEP/FiO₂ requirements: Yes/No
• Spontaneous breathing trial performed: Yes/No/Result: ___ 6

---

3. Post-Operative Cardiac Surgery Template

Hemodynamic Monitoring

• Arterial line BP: /
• CVP: ___ mmHg
• Cardiac output/index: ___
• Mixed venous O₂ saturation: ___
• Pulmonary artery pressures (if PA catheter): ___

Chest Tube Output:

• Mediastinal drainage last hour: ___ mL
• Total drainage since OR: ___ mL
• Character: Sanguineous/Serosanguineous/Serous

Coagulation Status:

• PT/INR: ___
• aPTT: ___
• Platelets: ___
• Fibrinogen: ___
• Active bleeding: Yes/No/Location: ___

Cardiac Rhythm:

• Current rhythm: ___
• Pacing: Yes/No, Mode: ___, Rate: ___
• Epicardial wires intact: Yes/No

Fluid Balance:

• Hourly urine output: ___ mL/kg/hr
• Cumulative balance: ___ mL

---

4. Severe Traumatic Brain Injury Template

Neurological Assessment (Hourly minimum)

Glasgow Coma Scale:

• Eye opening: ___/4
• Verbal response: ___/5
• Motor response: ___/6
• Total GCS: ___/15

Pupillary Examination:

• Right: Size ___ mm, Reactive: Yes/No
• Left: Size ___ mm, Reactive: Yes/No

Intracranial Pressure Management:

• ICP reading: ___ mmHg (target <20 mmHg)
• CPP: ___ mmHg (target 60-70 mmHg)
• Head of bed: 30 degrees elevation
• Head midline: Yes/No

Sedation/Analgesia:

• Agent: ___
• Sedation score: ___
• Paralytic agent if used: ___

Seizure Activity:

• Clinical seizures observed: Yes/No
• EEG monitoring: Yes/No, Findings: ___

Temperature Management:

• Current temperature: ___ °C
• Fever >38°C: Yes/No, Treatment: ___

---

5. Acute Ischemic Stroke Template

Neurological Assessment (Per protocol frequency) 7, 8

NIHSS Score: ___ (document every 15 min × 2h, then q30min × 6h, then hourly × 16h if post-thrombolysis) 8

Blood Pressure Management:

• Current BP: /
• Pre-thrombolysis target: SBP <185, DBP <110 mmHg 8
• Post-tPA target: SBP <180, DBP <105 mmHg 8
• Non-thrombolyzed target: Treat if SBP >220 or DBP >120 mmHg 8

Thrombolytic Therapy (if applicable):

• Symptom onset time: ___
• Door time: ___
• tPA bolus time: ___ (target door-to-needle <60 min) 8
• Dose: ___ mg

Monitoring Post-Thrombolysis:

• BP q15min × 2h, then q30min × 6h, then hourly × 16h 8
• Neurological checks same frequency
• Bleeding complications: Yes/No

Dysphagia Screening:

• Screen completed: Yes/No, Time: ___ (target <24h admission) 8
• Result: Pass/Fail
• If failed: SLP consult placed Yes/No

Glucose Monitoring:

• Current glucose: ___ (check q6h × 72h) 8
• Hypoglycemia/hyperglycemia treatment: ___

Cardiac Monitoring:

• Continuous monitoring first 24h: Yes/No 8
• Rhythm: ___
• Atrial fibrillation detected: Yes/No

---

6. Myocardial Infarction with Cardiogenic Shock Template

Hemodynamic Profile

Clinical Classification:

• Killip Class: I/II/III/IV
• Shock severity: Mild/Moderate/Severe

Vital Signs:

• BP: / (MAP: ___)
• Heart rate: ___
• Respiratory rate: ___
• O₂ saturation: ___

Perfusion Assessment:

• Skin: Warm/Cool/Mottled
• Capillary refill: ___ seconds
• Mental status: Alert/Confused/Obtunded
• Urine output: ___ mL/hr

Inotropic/Vasopressor Support:

• Agent 1: ___ at ___ mcg/kg/min
• Agent 2: ___ at ___ mcg/kg/min
• Escalating/Stable/Weaning

Mechanical Support:

• IABP: Yes/No, Timing: 1:1:2
• Impella/ECMO/Other: ___
• Device parameters: ___

Reperfusion Status:

• PCI performed: Yes/No, Time: ___
• Culprit vessel: ___
• TIMI flow post-intervention: ___
• Door-to-balloon time: ___ minutes

Laboratory Trending:

• Troponin: ___ (peak: ___)
• Lactate: ___
• BNP/NT-proBNP: ___

---

7. Diabetic Ketoacidosis Template

Metabolic Parameters (q1-2h initially)

Acid-Base Status:

• pH: ___ (target >7.30)
• Bicarbonate: ___ mEq/L (target >15)
• Anion gap: ___

Glucose Management:

• Current glucose: ___ mg/dL
• Insulin infusion rate: ___ units/hr
• Target glucose: 150-200 mg/dL (once gap closes)

Electrolytes:

• Sodium: ___ (corrected Na: ___)
• Potassium: ___ (target 4-5 mEq/L)
• Chloride: ___
• Phosphate: ___

Fluid Resuscitation:

• Initial bolus: ___ mL NS (if hypotensive)
• Maintenance rate: ___ mL/hr (0.9% NS then 0.45% NS)
• Total fluids given: ___ mL
• Urine output: ___ mL/hr

Ketone Monitoring:

• Beta-hydroxybutyrate: ___ or
• Urine ketones: Negative/Trace/Small/Moderate/Large

DKA Resolution Criteria Met:

• Glucose <200 mg/dL: Yes/No
• Anion gap ≤12: Yes/No
• Bicarbonate ≥18: Yes/No
• pH >7.30: Yes/No

---

8. Acute Renal Failure/AKI Template

Renal Function Assessment

AKI Stage (KDIGO):

• Stage 1: Cr 1.5-1.9× baseline or ≥0.3 mg/dL increase
• Stage 2: Cr 2.0-2.9× baseline
• Stage 3: Cr ≥3× baseline or ≥4.0 mg/dL or RRT initiated

Current Values:

• Creatinine: ___ (baseline: ___)
• BUN: ___
• Urine output: ___ mL/kg/hr (last 6h: ___ mL)
• Oliguria (<0.5 mL/kg/hr): Yes/No

Fluid Status:

• Daily weight: ___ kg (change from yesterday: ___)
• Cumulative fluid balance: ___ mL
• Fluid overload >10%: Yes/No
• Clinical signs: Edema/Rales/Ascites

Electrolyte Complications:

• Potassium: ___ (>6.0 requires urgent treatment)
• Bicarbonate: ___
• Calcium: ___
• Phosphate: ___

Renal Replacement Therapy:

• Indication present: Yes/No (Stage 3, refractory hyperkalemia, acidosis, uremia, fluid overload)
• Modality: CVVH/CVVHD/CVVHDF/IHD
• Prescription: ___
• Ultrafiltration goal: ___ mL/hr
• Anticoagulation: None/Heparin/Citrate

Nephrotoxin Exposure:

• Contrast within 48h: Yes/No
• Nephrotoxic medications: List ___
• Dose adjustments made: Yes/No

---

Key Documentation Principles

All templates should include:

• Date and time of assessment
• Nurse signature and credentials
• Physician notification of critical changes: Yes/No, Time: ___
• Family communication: Yes/No, Content: ___

Critical values requiring immediate physician notification should be clearly defined per institutional protocol and documented when thresholds are met.

These templates align with current evidence-based guidelines 4, 9, 4, 6, 7, 8 and incorporate standardized documentation elements shown to improve care quality 1, 2, 3.